octopamine

This page covers all octopamine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 3A, Trace amine-associated receptor 1, Trace amine-associated receptor 1.

Targets

5-hydroxytryptamine receptor 3A, Trace amine-associated receptor 1, Trace amine-associated receptor 1

Marketed (1)

• Norden · Neuroscience
  Norden works by binding to the 5-hydroxytryptamine receptor 3A, a subtype of serotonin receptor.

Patent intelligence

• octopamine patent landscape — aggregated cliff calendar, attackable patents, originator estates